#National Institutes of Health

Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.

Products based on broadly neutralizing antibodies could be used in HIV treatment and prevention.

The bill includes support for HIV research, the Ryan White HIV/AIDS programs and more. A date for the full House review has not been set.

The molecular biologist was the first to clone HIV, and she helped prove that the virus causes AIDS. She also researched cancer genetics.

This finding offers important insight into research on HIV cure therapies.

A recent NIH study found that adults have a much higher viral suppression rate than youth.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

Sexually transmitted infections reach all-time highs, notably among young people.

Amid talk of “ending HIV,” we must also focus on those with the virus, says Anthony S. Fauci, MD.

The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.

Interim guidance from HIVMA and AIDSinfo covers lab visits, opioid treatment programs, pregnant women and more.

Researchers used a harmless virus to deliver a gene for a broadly neutralizing HIV antibody to cells, which produced the antibody over time.

A recent NIH study found that adults have a much higher viral suppression rate than youth.

But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.

Researchers have been searching for agents that can wake HIV from its resting state in an effort to flush out the viral reservoir.

The American Cancer Society sets the record straight.